To investigate whether the remnant like particles (RLP), separated from serum by an immunoaffinity gel mixture of anti-apo B-100 and apo A-I monoclonal antibodies, are relevant to the initiation or progression of atherosclerosis, the incorporation of RLP into mouse macrophages was studied using histochemical and biochemical techniques. Remnant lipoproteins such as RLP are reported to contain a large quantity of chyloniron and very low density lipoprotein (VLDL) remnants, especially in diabetic patients.
Fatty streaks are regarded as the first gross lesion of atherosclerosis.
In these fatty streaks, there exist a number of foam cells derived from macrophages (1, 2) . The principle component in foam cells is believed to be cholesteryl esters coming from circulating lipoproteins. Goldstein et a/. (3) have reported that the native low density lipoprotein (LDL) itself is not taken up by macrophages, but that acetylated LDL is absorbed by macrophages.
However, because of the lesser possibility of acetylation occurring in vivo, the question of the origin of the chemically modified LDL arises. Steinberg et al. (4) reported that oxidized LDL cultured with arterial endothelial cells is accumulated by macrophages.
On the other hand, chylomicron remnants and VLDL remnants may also be accumulated in the macrophages (5) . It has been difficult to separate remnants satisfactorily because of the difficulty of their handling. However, based on a method developed by Japan Immunoresearch Laboratories, the remnant-like particles (RLP) containing a large quantity of chylomicron and VLDL remnants can be easily separated for further analyses (6, 7) . In fact, these RLP have often been found abundant in diabetic patients by this technique (8). Thus, RLP could be one of the factors in the acceleration of atherosclerosis in diabetic patients (9), since it is generally known that the circulating remnants often increase in diabetic patients.
In this study, the mouse peritoneal macrophages were cultured with the RLP separated from diabetic patients, to study the possible role of RLP in the foaming of macro- staining. Oil droplets were clearly observed as red spots in macrophages after incubation with RLP, but there were no oil droplets in the macrophages in the case of N-LDL .
RLP-VLDL uptake by macrophages
The readings of radioactivity incorporated into ester in macrophages after the incubation with PBS , N-LDL, N-VLDL, O-LDL or RLP concomitant with 14C-oleate were 8169 731 dpm, 8498 1142 dpm, 7228 1935 dpm , 10492 2356 dpm and 9468 1964 dpm, respectively.
Although there were no differences among readings of PBS , N-LDL and N-VLDL, that of O-LDL or RLP-VLDL was significantly higher than that of PBS, N-LDL and N-VLDL (p< 0 .05, respectively, Fig. 2 ). Therefore, applying the level of 14C-oleate incorporation in the case of N-LDL as a basal standard, the level of the uptake into macrophages in the case of RLP-VLDL were expressed by percentage against that in N-LDL for each patient . In 28 of 32 diabetic cases, they were over 100%. A significant relationship was seen between the levels of RLP-VLDL uptake and the glycemic control of diabetes i.e., HbAic (r= 0 .556, p< 0.01), as shown in Fig. 3 . However, we could not find any relationships between the RLP uptake and TC , TG, each of apoproteins, RLP-C or RLP-TG. glycation, the easier they are to be absorbed by macrophages. Glycation of RLP may lead to its further oxidation (17).
In conclusion, we suggest that RLP modified by glucose can be predominantly taken up by macrophages, and that this may explain the exasperated macroangiopathy i.e. atherosclerosis in diabetic patients.
Conclusion
We have found that RLP separated from the sera of diabetic patients is predominantly taken up by macrophages from mouse abdominal cavities by the oil red O staining.
RLP-VLDL was also suggested to contribute to the cholesteryloleate production for the foaming of macrophages, and this could be influenced by the patient's glycemic control. Therefore, RLP in turn may be relevant to the acceleration of atherosclerosis in diabetic patients.
